Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
02:30:03 10/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 104.71 USD | +2.52% |
|
+12.28% | +22.83% |
| 05/11 | UBS Adjusts Price Target on Edwards Lifesciences to $118 From $110, Maintains Buy Rating | MT |
| 05/11 | RBC Lifts Price Target on Edwards Lifesciences to $115 From $110, Keeps Outperform Rating | MT |
| Market Cap | 6.02TCr 5.37TCr 4.95TCr 4.49TCr 8.51TCr 5,64300Cr 8.72TCr 59TCr 24TCr 3,02100Cr 23TCr 22TCr 9,51600Cr | P/E 2026 * |
44.6x | P/E 2027 * | 32.3x |
|---|---|---|---|---|---|
| Enterprise Value | 5.67TCr 5.06TCr 4.65TCr 4.22TCr 8.01TCr 5,31200Cr 8.21TCr 56TCr 22TCr 2,84400Cr 21TCr 21TCr 8,95700Cr | EV / Sales 2026 * |
8.32x | EV / Sales 2027 * | 7.37x |
| Free-Float |
86.64% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +2.52% | ||
| 1 week | +12.28% | ||
| Current month | +13.80% | ||
| 1 month | +22.88% | ||
| 3 months | +16.71% | ||
| 6 months | +30.95% | ||
| Current year | +22.83% |
| 1 week | 96.72 |  | 105.37 |
| 1 month | 84.55 | | 105.37 |
| Current year | 74.66 | | 105.37 |
| 1 year | 74.66 | | 105.37 |
| 3 years | 58.93 | | 105.37 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/09/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/09/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.52% | +12.28% | +25.57% | +61.96% | 5.87TCr | |
| +3.87% | +5.71% | +26.07% | +62.43% | 26TCr | |
| +2.12% | +3.14% | +11.99% | +20.25% | 16TCr | |
| +1.71% | +5.42% | -17.76% | +69.07% | 16TCr | |
| +2.97% | -0.68% | -55.99% | -14.41% | 6.2TCr | |
| -3.36% | -0.55% | -0.30% | -10.70% | 5.54TCr | |
| +3.10% | +4.76% | +22.78% | +67.23% | 4.93TCr | |
| +0.88% | -0.20% | +3.91% | +83.91% | 4.92TCr | |
| +4.17% | +6.04% | +28.25% | +88.36% | 4.5TCr | |
| +2.00% | +5.63% | +15.03% | +23.01% | 3.72TCr | |
| Average | +2.00% | +4.03% | +5.96% | +45.11% | 9TCr | |
| Weighted average by Cap. | +2.37% | +4.40% | +7.53% | +47.81% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 681.21Cr 608.04Cr 559.51Cr 507.8Cr 962.36Cr 64TCr 986.25Cr 6.69TCr 2.67TCr 34TCr 2.56TCr 2.5TCr 1,07700Cr | 747.8Cr 667.49Cr 614.2Cr 557.45Cr 1.06TCr 70TCr 1.08TCr 7.35TCr 2.93TCr 38TCr 2.81TCr 2.75TCr 1,18200Cr |
| Net income | 136.47Cr 121.81Cr 112.09Cr 101.73Cr 192.79Cr 13TCr 197.58Cr 1.34TCr 534.43Cr 6.85TCr 512.21Cr 501.25Cr 22TCr | 184.57Cr 164.75Cr 151.6Cr 137.59Cr 260.75Cr 17TCr 267.22Cr 1.81TCr 722.82Cr 9.26TCr 692.77Cr 677.95Cr 29TCr |
| Net Debt | -353.57Cr -315.6Cr -290.4Cr -263.57Cr -499.5Cr -33TCr -511.9Cr -3.47TCr -1.38TCr -18TCr -1.33TCr -1.3TCr -56TCr | -509.45Cr -454.74Cr -418.44Cr -379.77Cr -719.72Cr -48TCr -737.59Cr -5.01TCr -2TCr -26TCr -1.91TCr -1.87TCr -81TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/26/09 | $104.71 | +2.52% | 66,83,068 |
| 06/26/06 | $102.14 | +1.31% | 51,12,770 |
| 05/26/05 | $100.82 | +1.46% | 92,33,947 |
| 04/26/04 | $99.37 | +4.39% | 78,97,496 |
| 03/26/03 | $95.19 | +2.07% | 65,59,254 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
